David Willner

机构：Bristol-Myers Squibb (United States)

发表论文 32 篇 · 总被引 2328 次 · h-index 17

代表论文

• Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates (1993 · Science · 被引 555)
• Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity (2002 · Bioconjugate Chemistry · 被引 554)
• (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin (1993 · Bioconjugate Chemistry · 被引 222)
• New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity (1991 · Bioconjugate Chemistry · 被引 162)
• Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains (2002 · Journal of Medicinal Chemistry · 被引 139)
• Antitumor activity of carcinoma-reactive BR96-doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinomas in immunocompetent rats. (1997 · PubMed · 被引 76)